D-Index & Metrics Best Publications

David Pickar

National Institutes of Health
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 88 Citations 27,409 332 World Ranking 8399 National Ranking 4489

Overview

What is he best known for?

The fields of study David Pickar is best known for:

Cognition
Corticotropin-releasing hormone
Dopamine

As part of his studies on Psychiatry, David Pickar often connects relevant areas like Pharmacotherapy. Schizophrenia (object-oriented programming) is closely attributed to Clozapine in his research. Clozapine and Schizophrenia (object-oriented programming) are commonly linked in his work. With his scientific publications, his incorporates both Clinical psychology and Psychopathology. He performs multidisciplinary study in the fields of Psychopathology and Clinical psychology via his papers. David Pickar incorporates Cognition and Psychomotor learning in his research. In his research, David Pickar undertakes multidisciplinary study on Psychomotor learning and Cognition. David Pickar merges Intensive care medicine with Psychiatry in his research. His work on Law expands to the thematically related MEDLINE.

His most cited work include:

Responses to Corticotropin-Releasing Hormone in the Hypercortisolism of Depression and Cushing's Disease (721 citations)
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery (286 citations)
The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia (273 citations)

What are the main themes of his work throughout his whole career to date

David Pickar regularly links together related areas like Anxiety in his Psychiatry studies. His Internal medicine study frequently links to adjacent areas such as Hormone. His Hormone study often links to related topics such as Internal medicine. Schizophrenia (object-oriented programming) is closely attributed to Clozapine in his study. His research links Schizophrenia (object-oriented programming) with Clozapine. His study connects beta-Endorphin and Endocrinology. His research brings together the fields of Endocrinology and beta-Endorphin. His study ties his expertise on Dopamine together with the subject of Neuroscience. He combines topics linked to Neuroscience with his work on Dopamine.

David Pickar most often published in these fields:

Psychiatry (58.33%)
Internal medicine (54.17%)
Schizophrenia (object-oriented programming) (41.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Alan Breier;T. P. Su;R. Saunders;R. E. Carson.
Proceedings of the National Academy of Sciences of the United States of America (1997)

1419 Citations

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.

P. W. Gold;D. L. Loriaux;A. Roy;M. A. Kling.
The New England Journal of Medicine (1986)

1078 Citations

National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia: Prognosis and Predictors of Outcome

Alan Breier;Judith L. Schreiber;Janyce Dyer;David Pickar.
Archives of General Psychiatry (1991)

902 Citations

NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

Anil K. Malhotra;Debra A. Pinals;Herbert Weingartner;Karen Sirocco.
Neuropsychopharmacology (1996)

789 Citations

Effort and Cognition in Depression

Robert M. Cohen;Herbert Weingartner;Sheila A. Smallberg;David Pickar.
Archives of General Psychiatry (1982)

582 Citations

Cognitive effects of corticosteroids.

Owen M. Wolkowitz;Victor I. Reus;Victor I. Reus;Victor I. Reus;Herbert Weingartner;Herbert Weingartner;Herbert Weingartner;Karen Thompson;Karen Thompson;Karen Thompson.
American Journal of Psychiatry (1990)

524 Citations

Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers

Tung Ping Su;Michael Pagliaro;Peter J. Schmidt;David Pickar.
JAMA (1993)

510 Citations

Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders.

Monte S. Buchsbaum;Lynn E. DeLisi;Henry H. Holcomb;John Cappelletti.
Archives of General Psychiatry (1984)

482 Citations

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.

David Pickar;Richard R. Owen;Robert E. Litman;P. Eric Konicki.
Archives of General Psychiatry (1992)

466 Citations

Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery

T E Goldberg;J M Gold;R Greenberg;S Griffin.
American Journal of Psychiatry (1993)

463 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for David Pickar